MedTrace Logo

Assessment of Burden Disease in Patients With Mast Cell Disorders

NCT04615663 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-11-04

No results posted yet for this study

Summary

The symptoms caused by mast cell disorders can have a significant impact on the state of health of individuals, constituting a real burden for them, and consequently altering their quality of life. It therefore seems important to clarify the impact on the quality of life, on the psycho-affective sphere, on professional life and on the direct and indirect costs caused by the disease, as well as on the "patient's remaining burden". It seems possible by a longitudinal study (patient follow-up over 1 year).

Primary objective is Assessment of quality of life in adult patient with mast cell diseases at M0.

Conditions

  • Mastocytosis
  • Cutaneous

Interventions

BEHAVIORAL

Score SMI

the investigator will complete the SMI score

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • LIVIDEANU Cristina, MD · University Hospital, Toulouse

Eligibility

Min Age
18 Months
Max Age
65 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2021-01-28
Completion
2022-09-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04615663 on ClinicalTrials.gov